Open-label, phase II, multicentre study on cetuximab treatment as first-line monotherapy in elderly patients with metastatic colorectal cancer expressing EGFR.
Phase of Trial: Phase II
Latest Information Update: 21 Jun 2011
At a glance
- Drugs Cetuximab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 21 Jun 2011 New trial record